\-\ Texto\\:\\ \ \(0\)\
\-\ neoplasm\\ name\\:\\ medulloblastoma\\ \ \(0\)\
\-\ synonyms\\:\\ pnet\\ \\(primitive\\ neuroectodermal\\ tumor\\)\\,\\ central\\ neuroblastoma\\ \ \(0\)\
\-\ cell\\ of\\ origin\\:\\ \ \(0\)\
\-\ cell\\ of\\ origin\\ is\\ not\\ clear\\.\\ several\\ choices\\ have\\ been\\ offered\\:\\ \ \(0\)\
\-\ 1\\)\\ \\'medulloblasts\\'\\ \ \(5\)\
\-\ 2\\)\\ external\\ granular\\ cells\\ \ \(5\)\
\-\ 3\\)\\ subependymal\\ matrix\\ cells\\ \ \(5\)\
\-\ 4\\)\\ more\\ than\\ one\\ cell\\ of\\ origin\\ \ \(5\)\
\-\ who\\ grade\\(s\\)\\:\\ who\\ 4\\ \ \(0\)\
\-\ genetics\\ and\\ associations\\:\\ \ \(0\)\
\-\ demographics\\ \\(age\\,\\ sex\\,\\ incidence\\)\\:\\ \ \(0\)\
\-\ peak\\ age\\ is\\ 7\\,\\ 70\\%\\ \\<16\\ \\(30\\%\\>15\\)\\,\\ most\\ adults\\ \\<40\\ \ \(0\)\
\-\ 65\\%\\ male\\ \\(\\~2\\:1\\ m\\:f\\)\\ \ \(0\)\
\-\ incidence\\ \\-\\ 0\\.5\\/100k\\ in\\ children\\ \\(\\<15\\ yo\\)\\ \ \(0\)\
\-\ common\\ locations\\:\\ \ \(0\)\
\-\ posterior\\ fossa\\,\\ usually\\ midline\\ \ \(0\)\
\-\ gross\\ appearance\\:\\ \ \(0\)\
\-\ varies\\ from\\ soft\\ to\\ firm\\,\\ some\\ are\\ well\\ defined\\,\\ may\\ be\\ hemorrhagic\\ \ \(0\)\
\-\ radiology\\:\\ \ \(3\)\
\-\ relatively\\ homogeneous\\,\\ may\\ be\\ uniformly\\ hyperdense\\ on\\ non\\-contrast\\ ct\\.\\ mr\\ signal\\ similar\\ to\\ gray\\-matter\\,\\ most\\ not\\ bright\\ on\\ t2w\\ mr\\ \ \(0\)\
\-\ histology\\:\\ \ \(0\)\
\-\ densely\\ cellular\\,\\ hyperchromatic\\ \\"carrot\\-shaped\\"\\ nuclei\\,\\ high\\ nuclear\\ to\\ cytoplasm\\ ratio\\,\\ neuroblastic\\ rosettes\\ \ \(0\)\
\-\ special\\ stains\\:\\ \ \(0\)\
\-\ prognosis\\ and\\ treatment\\:\\ \ \(0\)\
\-\ survival\\ up\\ to\\ 85\\%\\ at\\ five\\ years\\ with\\ combined\\ radiation\\ and\\ chemotherapy\\ \\[magnani\\ c\\,\\ pastore\\ g\\:\\ survival\\ of\\ childhood\\ cancer\\ patients\\ in\\ italy\\,1978\\-1989\\.\\ itacare\\ working\\ group\\.tumori\\ 1997\\ jan\\-feb\\;83\\(1\\)\\:426\\-89\\.\\ \ \(0\)\
\-\ up\\ to\\ 100\\%\\ in\\ pts\\.\\ w\\/o\\ csf\\ spread\\ \\(bourne\\ 1992\\ j\\ neurooncol\\)\\ \ \(0\)\
\-\ \\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\ \ \(5\)\
\-\ see\\ also\\:\ \(0\)\
\-\ neoplasm\\ name\\:\\ medulloblastoma\\ \ \(0\)\
\-\ synonyms\\:\\ pnet\\ \\(primitive\\ neuroectodermal\\ tumor\\)\\,\\ central\\ neuroblastoma\\ \ \(0\)\
\-\ cell\\ of\\ origin\\:\\ \ \(0\)\
\-\ cell\\ of\\ origin\\ is\\ not\\ clear\\.\\ several\\ choices\\ have\\ been\\ offered\\:\\ \ \(0\)\
\-\ 1\\)\\ \\'medulloblasts\\'\\ \ \(5\)\
\-\ 2\\)\\ external\\ granular\\ cells\\ \ \(5\)\
\-\ 3\\)\\ subependymal\\ matrix\\ cells\\ \ \(5\)\
\-\ 4\\)\\ more\\ than\\ one\\ cell\\ of\\ origin\\ \ \(5\)\
\-\ who\\ grade\\(s\\)\\:\\ who\\ 4\\ \ \(0\)\
\-\ genetics\\ and\\ associations\\:\\ \ \(0\)\
\-\ demographics\\ \\(age\\,\\ sex\\,\\ incidence\\)\\:\\ \ \(0\)\
\-\ peak\\ age\\ is\\ 7\\,\\ 70\\%\\ \\<16\\ \\(30\\%\\>15\\)\\,\\ most\\ adults\\ \\<40\\ \ \(0\)\
\-\ 65\\%\\ male\\ \\(\\~2\\:1\\ m\\:f\\)\\ \ \(0\)\
\-\ incidence\\ \\-\\ 0\\.5\\/100k\\ in\\ children\\ \\(\\<15\\ yo\\)\\ \ \(0\)\
\-\ common\\ locations\\:\\ \ \(0\)\
\-\ posterior\\ fossa\\,\\ usually\\ midline\\ \ \(0\)\
\-\ gross\\ appearance\\:\\ \ \(0\)\
\-\ varies\\ from\\ soft\\ to\\ firm\\,\\ some\\ are\\ well\\ defined\\,\\ may\\ be\\ hemorrhagic\\ \ \(0\)\
\-\ radiology\\:\\ \ \(3\)\
\-\ relatively\\ homogeneous\\,\\ may\\ be\\ uniformly\\ hyperdense\\ on\\ non\\-contrast\\ ct\\.\\ mr\\ signal\\ similar\\ to\\ gray\\-matter\\,\\ most\\ not\\ bright\\ on\\ t2w\\ mr\\ \ \(0\)\
\-\ histology\\:\\ \ \(0\)\
\-\ densely\\ cellular\\,\\ hyperchromatic\\ \\"carrot\\-shaped\\"\\ nuclei\\,\\ high\\ nuclear\\ to\\ cytoplasm\\ ratio\\,\\ neuroblastic\\ rosettes\\ \ \(0\)\
\-\ special\\ stains\\:\\ \ \(0\)\
\-\ prognosis\\ and\\ treatment\\:\\ \ \(0\)\
\-\ survival\\ up\\ to\\ 85\\%\\ at\\ five\\ years\\ with\\ combined\\ radiation\\ and\\ chemotherapy\\ \\[magnani\\ c\\,\\ pastore\\ g\\:\\ survival\\ of\\ childhood\\ cancer\\ patients\\ in\\ italy\\,1978\\-1989\\.\\ itacare\\ working\\ group\\.tumori\\ 1997\\ jan\\-feb\\;83\\(1\\)\\:426\\-89\\.\\ \ \(0\)\
\-\ up\\ to\\ 100\\%\\ in\\ pts\\.\\ w\\/o\\ csf\\ spread\\ \\(bourne\\ 1992\\ j\\ neurooncol\\)\\ \ \(0\)\
\-\ \\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\ \ \(5\)\
\-\ see\\ also\\:\ \(0\)\
\-\ neoplasm\\ name\\:\\ medulloblastoma\\ \ \(0\)\
\-\ synonyms\\:\\ pnet\\ \\(primitive\\ neuroectodermal\\ tumor\\)\\,\\ central\\ neuroblastoma\\ \ \(0\)\
\-\ cell\\ of\\ origin\\:\\ \ \(0\)\
\-\ cell\\ of\\ origin\\ is\\ not\\ clear\\.\\ several\\ choices\\ have\\ been\\ offered\\:\\ \ \(0\)\
\-\ 1\\)\\ \\'medulloblasts\\'\\ \ \(5\)\
\-\ 2\\)\\ external\\ granular\\ cells\\ \ \(5\)\
\-\ 3\\)\\ subependymal\\ matrix\\ cells\\ \ \(5\)\
\-\ 4\\)\\ more\\ than\\ one\\ cell\\ of\\ origin\\ \ \(5\)\
\-\ who\\ grade\\(s\\)\\:\\ who\\ 4\\ \ \(0\)\
\-\ genetics\\ and\\ associations\\:\\ \ \(0\)\
\-\ demographics\\ \\(age\\,\\ sex\\,\\ incidence\\)\\:\\ \ \(0\)\
\-\ peak\\ age\\ is\\ 7\\,\\ 70\\%\\ \\<16\\ \\(30\\%\\>15\\)\\,\\ most\\ adults\\ \\<40\\ \ \(0\)\
\-\ 65\\%\\ male\\ \\(\\~2\\:1\\ m\\:f\\)\\ \ \(0\)\
\-\ incidence\\ \\-\\ 0\\.5\\/100k\\ in\\ children\\ \\(\\<15\\ yo\\)\\ \ \(0\)\
\-\ common\\ locations\\:\\ \ \(0\)\
\-\ posterior\\ fossa\\,\\ usually\\ midline\\ \ \(0\)\
\-\ gross\\ appearance\\:\\ \ \(0\)\
\-\ varies\\ from\\ soft\\ to\\ firm\\,\\ some\\ are\\ well\\ defined\\,\\ may\\ be\\ hemorrhagic\\ \ \(0\)\
\-\ radiology\\:\\ \ \(3\)\
\-\ relatively\\ homogeneous\\,\\ may\\ be\\ uniformly\\ hyperdense\\ on\\ non\\-contrast\\ ct\\.\\ mr\\ signal\\ similar\\ to\\ gray\\-matter\\,\\ most\\ not\\ bright\\ on\\ t2w\\ mr\\ \ \(0\)\
\-\ histology\\:\\ \ \(0\)\
\-\ densely\\ cellular\\,\\ hyperchromatic\\ \\"carrot\\-shaped\\"\\ nuclei\\,\\ high\\ nuclear\\ to\\ cytoplasm\\ ratio\\,\\ neuroblastic\\ rosettes\\ \ \(0\)\
\-\ special\\ stains\\:\\ \ \(0\)\
\-\ prognosis\\ and\\ treatment\\:\\ \ \(0\)\
\-\ survival\\ up\\ to\\ 85\\%\\ at\\ five\\ years\\ with\\ combined\\ radiation\\ and\\ chemotherapy\\ \\[magnani\\ c\\,\\ pastore\\ g\\:\\ survival\\ of\\ childhood\\ cancer\\ patients\\ in\\ italy\\,1978\\-1989\\.\\ itacare\\ working\\ group\\.tumori\\ 1997\\ jan\\-feb\\;83\\(1\\)\\:426\\-89\\.\\ \ \(0\)\
\-\ up\\ to\\ 100\\%\\ in\\ pts\\.\\ w\\/o\\ csf\\ spread\\ \\(bourne\\ 1992\\ j\\ neurooncol\\)\\ \ \(0\)\
\-\ \\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\ \ \(5\)\
\-\ see\\ also\\:\ \(0\)\
\-\ medulloblastoma\ \(30\)\
\-\ neoplasm\\ name\\:\\ medulloblastoma\\ \ \(0\)\
\-\ synonyms\\:\\ pnet\\ \\(primitive\\ neuroectodermal\\ tumor\\)\\,\\ central\\ neuroblastoma\\ \ \(0\)\
\-\ cell\\ of\\ origin\\:\\ \ \(0\)\
\-\ cell\\ of\\ origin\\ is\\ not\\ clear\\.\\ several\\ choices\\ have\\ been\\ offered\\:\\ \ \(0\)\
\-\ 1\\)\\ \\'medulloblasts\\'\\ \ \(5\)\
\-\ 2\\)\\ external\\ granular\\ cells\\ \ \(5\)\
\-\ 3\\)\\ subependymal\\ matrix\\ cells\\ \ \(5\)\
\-\ 4\\)\\ more\\ than\\ one\\ cell\\ of\\ origin\\ \ \(5\)\
\-\ who\\ grade\\(s\\)\\:\\ who\\ 4\\ \ \(0\)\
\-\ genetics\\ and\\ associations\\:\\ \ \(0\)\
\-\ demographics\\ \\(age\\,\\ sex\\,\\ incidence\\)\\:\\ \ \(0\)\
\-\ peak\\ age\\ is\\ 7\\,\\ 70\\%\\ \\<16\\ \\(30\\%\\>15\\)\\,\\ most\\ adults\\ \\<40\\ \ \(0\)\
\-\ 65\\%\\ male\\ \\(\\~2\\:1\\ m\\:f\\)\\ \ \(0\)\
\-\ incidence\\ \\-\\ 0\\.5\\/100k\\ in\\ children\\ \\(\\<15\\ yo\\)\\ \ \(0\)\
\-\ common\\ locations\\:\\ \ \(0\)\
\-\ posterior\\ fossa\\,\\ usually\\ midline\\ \ \(0\)\
\-\ gross\\ appearance\\:\\ \ \(0\)\
\-\ varies\\ from\\ soft\\ to\\ firm\\,\\ some\\ are\\ well\\ defined\\,\\ may\\ be\\ hemorrhagic\\ \ \(0\)\
\-\ radiology\\:\\ \ \(3\)\
\-\ relatively\\ homogeneous\\,\\ may\\ be\\ uniformly\\ hyperdense\\ on\\ non\\-contrast\\ ct\\.\\ mr\\ signal\\ similar\\ to\\ gray\\-matter\\,\\ most\\ not\\ bright\\ on\\ t2w\\ mr\\ \ \(0\)\
\-\ histology\\:\\ \ \(0\)\
\-\ densely\\ cellular\\,\\ hyperchromatic\\ \\"carrot\\-shaped\\"\\ nuclei\\,\\ high\\ nuclear\\ to\\ cytoplasm\\ ratio\\,\\ neuroblastic\\ rosettes\\ \ \(0\)\
\-\ special\\ stains\\:\\ \ \(0\)\
\-\ prognosis\\ and\\ treatment\\:\\ \ \(0\)\
\-\ survival\\ up\\ to\\ 85\\%\\ at\\ five\\ years\\ with\\ combined\\ radiation\\ and\\ chemotherapy\\ \\[magnani\\ c\\,\\ pastore\\ g\\:\\ survival\\ of\\ childhood\\ cancer\\ patients\\ in\\ italy\\,1978\\-1989\\.\\ itacare\\ working\\ group\\.tumori\\ 1997\\ jan\\-feb\\;83\\(1\\)\\:426\\-89\\.\\ \ \(0\)\
\-\ up\\ to\\ 100\\%\\ in\\ pts\\.\\ w\\/o\\ csf\\ spread\\ \\(bourne\\ 1992\\ j\\ neurooncol\\)\\ \ \(0\)\
\-\ \\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\ \ \(5\)\
\-\ see\\ also\\:\ \(0\)\
\-\ neoplasm\\ name\\:\\ medulloblastoma\\ \ \(0\)\
\-\ synonyms\\:\\ pnet\\ \\(primitive\\ neuroectodermal\\ tumor\\)\\,\\ central\\ neuroblastoma\\ \ \(0\)\
\-\ cell\\ of\\ origin\\:\\ \ \(0\)\
\-\ cell\\ of\\ origin\\ is\\ not\\ clear\\.\\ several\\ choices\\ have\\ been\\ offered\\:\\ \ \(0\)\
\-\ 1\\)\\ \\'medulloblasts\\'\\ \ \(5\)\
\-\ 2\\)\\ external\\ granular\\ cells\\ \ \(5\)\
\-\ 3\\)\\ subependymal\\ matrix\\ cells\\ \ \(5\)\
\-\ 4\\)\\ more\\ than\\ one\\ cell\\ of\\ origin\\ \ \(5\)\
\-\ who\\ grade\\(s\\)\\:\\ who\\ 4\\ \ \(0\)\
\-\ genetics\\ and\\ associations\\:\\ \ \(0\)\
\-\ demographics\\ \\(age\\,\\ sex\\,\\ incidence\\)\\:\\ \ \(0\)\
\-\ peak\\ age\\ is\\ 7\\,\\ 70\\%\\ \\<16\\ \\(30\\%\\>15\\)\\,\\ most\\ adults\\ \\<40\\ \ \(0\)\
\-\ 65\\%\\ male\\ \\(\\~2\\:1\\ m\\:f\\)\\ \ \(0\)\
\-\ incidence\\ \\-\\ 0\\.5\\/100k\\ in\\ children\\ \\(\\<15\\ yo\\)\\ \ \(0\)\
\-\ common\\ locations\\:\\ \ \(0\)\
\-\ posterior\\ fossa\\,\\ usually\\ midline\\ \ \(0\)\
\-\ gross\\ appearance\\:\\ \ \(0\)\
\-\ varies\\ from\\ soft\\ to\\ firm\\,\\ some\\ are\\ well\\ defined\\,\\ may\\ be\\ hemorrhagic\\ \ \(0\)\
\-\ radiology\\:\\ \ \(3\)\
\-\ relatively\\ homogeneous\\,\\ may\\ be\\ uniformly\\ hyperdense\\ on\\ non\\-contrast\\ ct\\.\\ mr\\ signal\\ similar\\ to\\ gray\\-matter\\,\\ most\\ not\\ bright\\ on\\ t2w\\ mr\\ \ \(0\)\
\-\ histology\\:\\ \ \(0\)\
\-\ densely\\ cellular\\,\\ hyperchromatic\\ \\"carrot\\-shaped\\"\\ nuclei\\,\\ high\\ nuclear\\ to\\ cytoplasm\\ ratio\\,\\ neuroblastic\\ rosettes\\ \ \(0\)\
\-\ special\\ stains\\:\\ \ \(0\)\
\-\ prognosis\\ and\\ treatment\\:\\ \ \(0\)\
\-\ survival\\ up\\ to\\ 85\\%\\ at\\ five\\ years\\ with\\ combined\\ radiation\\ and\\ chemotherapy\\ \\[magnani\\ c\\,\\ pastore\\ g\\:\\ survival\\ of\\ childhood\\ cancer\\ patients\\ in\\ italy\\,1978\\-1989\\.\\ itacare\\ working\\ group\\.tumori\\ 1997\\ jan\\-feb\\;83\\(1\\)\\:426\\-89\\.\\ \ \(0\)\
\-\ up\\ to\\ 100\\%\\ in\\ pts\\.\\ w\\/o\\ csf\\ spread\\ \\(bourne\\ 1992\\ j\\ neurooncol\\)\\ \ \(0\)\
\-\ \\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\ \ \(5\)\
\-\ see\\ also\\:\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\:\\:\\ 0\\.07256981162058844\ \(0\)\
\-\ origin\\:\\ 0\\.04716306529713789\ \(0\)\
\-\ \\%\\:\\ 0\\.03999440275573852\ \(0\)\
\-\ \\<\\:\\ 0\\.03970383861358496\ \(0\)\
\-\ survival\\:\\ 0\\.03676895601419934\ \(0\)\
\-\ \\'medulloblasts\\:\\ 0\\.03537527457450441\ \(0\)\
\-\ \\~2\\:1\\:\\ 0\\.03537527457450441\ \(0\)\
\-\ 0\\.5\\/100k\\:\\ 0\\.03537527457450441\ \(0\)\
\-\ carrot\\-shaped\\:\\ 0\\.03537527457450441\ \(0\)\
\-\ neuroblastic\\:\\ 0\\.03537527457450441\ \(0\)\
\-\ magnani\\:\\ 0\\.03537527457450441\ \(0\)\
\-\ pastore\\:\\ 0\\.03537527457450441\ \(0\)\
\-\ italy\\,1978\\-1989\\:\\ 0\\.03537527457450441\ \(0\)\
\-\ itacare\\:\\ 0\\.03537527457450441\ \(0\)\
\-\ group\\.tumori\\:\\ 0\\.03537527457450441\ \(0\)\
\-\ \\:426\\-89\\.\\:\\ 0\\.03537527457450441\ \(0\)\
\-\ \\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\:\\ 0\\.03537527457450441\ \(0\)\
\-\ \\)\\:\\ 0\\.034359760454894306\ \(0\)\
\-\ rosettes\\:\\ 0\\.03259378508590109\ \(0\)\
\-\ jan\\-feb\\:\\ 0\\.03259378508590109\ \(0\)\
\-\ bourne\\:\\ 0\\.03259378508590109\ \(0\)\
\-\ neurooncol\\:\\ 0\\.03259378508590109\ \(0\)\
\-\ incidence\\:\\ 0\\.031442043531425254\ \(0\)\
\-\ hyperchromatic\\:\\ 0\\.030966718038918088\ \(0\)\
\-\ choices\\:\\ 0\\.02981229559729778\ \(0\)\
\-\ synonyms\\:\\ 0\\.028185228550314776\ \(0\)\
\-\ cell\\:\\ 0\\.027787809529472147\ \(0\)\
\-\ gray\\-matter\\:\\ 0\\.027566646368022408\ \(0\)\
\-\ cells\\:\\ 0\\.027499572184189382\ \(0\)\
\-\ 15\\:\\ 0\\.027354307002458902\ \(0\)\
\-\ associations\\:\\ 0\\.026558161503331772\ \(0\)\
\-\ cytoplasm\\:\\ 0\\.026558161503331772\ \(0\)\
\-\ demographics\\:\\ 0\\.024785156879419096\ \(0\)\
\-\ densely\\:\\ 0\\.024785156879419096\ \(0\)\
\-\ genetics\\:\\ 0\\.024508299449696177\ \(0\)\
\-\ uniformly\\:\\ 0\\.024508299449696177\ \(0\)\
\-\ neuroectodermal\\:\\ 0\\.024249316620091155\ \(0\)\
\-\ sex\\:\\ 0\\.02400603964650996\ \(0\)\
\-\ medulloblastoma\\:\\ 0\\.0239102928840599\ \(0\)\
\-\ name\\:\\ 0\\.023776672014728464\ \(0\)\
\-\ granular\\:\\ 0\\.023776672014728464\ \(0\)\
\-\ pts\\:\\ 0\\.023776672014728464\ \(0\)\
\-\ 1992\\:\\ 0\\.023776672014728464\ \(0\)\
\-\ offered\\:\\ 0\\.02335387700807587\ \(0\)\
\-\ stains\\:\\ 0\\.02335387700807587\ \(0\)\
\-\ \\(\\:\\ 0\\.023189782543944156\ \(0\)\
\-\ cellular\\:\\ 0\\.022971412402119508\ \(0\)\
\-\ varies\\:\\ 0\\.02245843739606058\ \(0\)\
\-\ primitive\\:\\ 0\\.02230105090668144\ \(0\)\
\-\ special\\:\\ 0\\.02230105090668144\ \(0\)\
\-\ working\\:\\ 0\\.021862851500722404\ \(0\)\
\-\ mr\\:\\ 0\\.021791328025252278\ \(0\)\
\-\ nuclei\\:\\ 0\\.021467827131487843\ \(0\)\
\-\ 83\\:\\ 0\\.020885234796638334\ \(0\)\
\-\ age\\:\\ 0\\.020874079659264095\ \(0\)\
\-\ pnet\\:\\ 0\\.02077821935890896\ \(0\)\
\-\ subependymal\\:\\ 0\\.020473299989013604\ \(0\)\
\-\ histology\\:\\ 0\\.02037660034383278\ \(0\)\
\-\ g\\:\\ 0\\.02028217619692189\ \(0\)\
\-\ locations\\:\\ 0\\.020011545054082674\ \(0\)\
\-\ peak\\:\\ 0\\.01951956141807813\ \(0\)\
\-\ w\\/o\\:\\ 0\\.019368115479142148\ \(0\)\
\-\ childhood\\:\\ 0\\.01929448330150091\ \(0\)\
\-\ t2w\\:\\ 0\\.01922217790221247\ \(0\)\
\-\ 1997\\:\\ 0\\.01922217790221247\ \(0\)\
\-\ matrix\\:\\ 0\\.019151152311925955\ \(0\)\
\-\ 85\\:\\ 0\\.019151152311925955\ \(0\)\
\-\ 4\\:\\ 0\\.01910892379758463\ \(0\)\
\-\ ratio\\:\\ 0\\.01901276476749911\ \(0\)\
\-\ combined\\:\\ 0\\.018945320472489556\ \(0\)\
\-\ up\\:\\ 0\\.018441790939439994\ \(0\)\
\-\ f\\:\\ 0\\.01789249437109513\ \(0\)\
\-\ \\[\\:\\ 0\\.01789249437109513\ \(0\)\
\-\ who\\:\\ 0\\.017880966365503227\ \(0\)\
\-\ m\\:\\ 0\\.017691810500410292\ \(0\)\
\-\ nuclear\\:\\ 0\\.017691810500410292\ \(0\)\
\-\ adults\\:\\ 0\\.01750068670831858\ \(0\)\
\-\ \\'\\:\\ 0\\.017408433424912887\ \(0\)\
\-\ 100\\:\\ 0\\.017318253425506552\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.017143754581446607\ \(0\)\
\-\ hyperdense\\:\\ 0\\.017143754581446607\ \(0\)\
\-\ bright\\:\\ 0\\.017143754581446607\ \(0\)\
\-\ five\\:\\ 0\\.01710129025829036\ \(0\)\
\-\ firm\\:\\ 0\\.016815993622320332\ \(0\)\
\-\ 65\\:\\ 0\\.01673807192947482\ \(0\)\
\-\ non\\-contrast\\:\\ 0\\.01673807192947482\ \(0\)\
\-\ spread\\:\\ 0\\.016586625990538836\ \(0\)\
\-\ 70\\:\\ 0\\.016476678261052022\ \(0\)\
\-\ gross\\:\\ 0\\.016334615953464075\ \(0\)\
\-\ 1\\:\\ 0\\.016318831203528946\ \(0\)\
\-\ c\\:\\ 0\\.016299872523515783\ \(0\)\
\-\ prognosis\\:\\ 0\\.016265427324112125\ \(0\)\
\-\ homogeneous\\:\\ 0\\.0162312752788958\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.01600001880683867\ \(0\)\
\-\ most\\:\\ 0\\.015833347846934798\ \(0\)\
\-\ 16\\:\\ 0\\.015516687534463601\ \(0\)\
\-\ j\\:\\ 0\\.015488328115430326\ \(0\)\
\-\ \\,\\:\\ 0\\.015208430647038616\ \(0\)\
\-\ may\\:\\ 0\\.015042763795330046\ \(0\)\
\-\ children\\:\\ 0\\.014813621366626159\ \(0\)\
\-\ relatively\\:\\ 0\\.01467280547653278\ \(0\)\
\-\ external\\:\\ 0\\.014581600616670999\ \(0\)\
\-\ radiology\\:\\ 0\\.014492422700199448\ \(0\)\
\-\ defined\\:\\ 0\\.014448566076876052\ \(0\)\
\-\ 40\\:\\ 0\\.014426816207416425\ \(0\)\
\-\ csf\\:\\ 0\\.014319800769687046\ \(0\)\
\-\ fossa\\:\\ 0\\.013975921471513358\ \(0\)\
\-\ similar\\:\\ 0\\.013449785790292488\ \(0\)\
\-\ midline\\:\\ 0\\.013266974668292618\ \(0\)\
\-\ 30\\:\\ 0\\.013186554319643157\ \(0\)\
\-\ 7\\:\\ 0\\.013139064521701733\ \(0\)\
\-\ grade\\:\\ 0\\.01306114282885622\ \(0\)\
\-\ clear\\:\\ 0\\.01267867822289986\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.012291114707627868\ \(0\)\
\-\ neoplasm\\:\\ 0\\.011677995890497303\ \(0\)\
\-\ \\>\\:\\ 0\\.011393128068493436\ \(0\)\
\-\ central\\:\\ 0\\.011282629842937235\ \(0\)\
\-\ cancer\\:\\ 0\\.011272733805637099\ \(0\)\
\-\ radiation\\:\\ 0\\.011253014645113708\ \(0\)\
\-\ several\\:\\ 0\\.011023647013332213\ \(0\)\
\-\ be\\:\\ 0\\.010575896656050795\ \(0\)\
\-\ usually\\:\\ 0\\.01041303472659213\ \(0\)\
\-\ some\\:\\ 0\\.01041303472659213\ \(0\)\
\-\ yo\\:\\ 0\\.01031842505338187\ \(0\)\
\-\ see\\:\\ 0\\.010233616417450995\ \(0\)\
\-\ years\\:\\ 0\\.010069193968774006\ \(0\)\
\-\ not\\:\\ 0\\.009910262213017136\ \(0\)\
\-\ s\\:\\ 0\\.009834541200299305\ \(0\)\
\-\ appearance\\:\\ 0\\.009807008734890214\ \(0\)\
\-\ high\\:\\ 0\\.009384213728237622\ \(0\)\
\-\ been\\:\\ 0\\.009329032461733512\ \(0\)\
\-\ one\\:\\ 0\\.009292662051808362\ \(0\)\
\-\ signal\\:\\ 0\\.009041229254706174\ \(0\)\
\-\ than\\:\\ 0\\.008984947250875898\ \(0\)\
\-\ common\\:\\ 0\\.008973784959696618\ \(0\)\
\-\ patients\\:\\ 0\\.008874697429237664\ \(0\)\
\-\ more\\:\\ 0\\.008576148913772737\ \(0\)\
\-\ to\\:\\ 0\\.008568782272130543\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.008427508176692685\ \(0\)\
\-\ soft\\:\\ 0\\.008350428426940408\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.008265447439736126\ \(0\)\
\-\ \\;\\:\\ 0\\.008127693372602702\ \(0\)\
\-\ 3\\:\\ 0\\.008029596816639404\ \(0\)\
\-\ tumor\\:\\ 0\\.007994511643703094\ \(0\)\
\-\ posterior\\:\\ 0\\.007903846503621382\ \(0\)\
\-\ well\\:\\ 0\\.007757146681254618\ \(0\)\
\-\ have\\:\\ 0\\.007425513958126371\ \(0\)\
\-\ 2\\:\\ 0\\.007384046936238146\ \(0\)\
\-\ \\-\\:\\ 0\\.007350435227561651\ \(0\)\
\-\ treatment\\:\\ 0\\.006940678008029241\ \(0\)\
\-\ also\\:\\ 0\\.006760110729013447\ \(0\)\
\-\ male\\:\\ 0\\.006200664277237051\ \(0\)\
\-\ on\\:\\ 0\\.005809719200364591\ \(0\)\
\-\ from\\:\\ 0\\.005082005269479183\ \(0\)\
\-\ in\\:\\ 0\\.00507300036284416\ \(0\)\
\-\ ct\\:\\ 0\\.004796563617143029\ \(0\)\
\-\ are\\:\\ 0\\.004674453742093104\ \(0\)\
\-\ at\\:\\ 0\\.004645919553899008\ \(0\)\
\-\ is\\:\\ 0\\.0045127670817393705\ \(0\)\
\-\ and\\:\\ 0\\.002167042605123015\ \(0\)\
\-\ of\\:\\ 0\\.0018700449566290277\ \(0\)\
\-\ \\.\\:\\ 0\\.000569815988721449\ \(0\)\
\-\ with\\:\\ 0\\.00046951916568976616\ \(0\)\
